Database Surveillance Safety Study of PENTACEL® Vaccine

Completed

Conditions studied: Diphtheria, Tetanus, Pertussis, Haemophilus Influenzae

In brief

The objective for this study is to characterize the safety profile of PENTACEL® vaccine for identification of potential vaccine-related adverse events not currently associated with PENTACEL® vaccine administration.

Key facts

Study ID

NCT00804284

Run by

Sanofi Pasteur, a Sanofi Company

People needed

62538

Starts

2008-09-01

Expected to finish

2015-01-01

Last updated by the study team

2015-08-19

Who can join

Age: 0 and older, up to 2. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Receipt of DTaP vaccine during the study period by a previously unvaccinated child

You may not qualify if…

• None

Where it is running

• Study site — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.